Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

Transfusion Science

Volumn 23, Issue 3, 2000, Pages 241-242

  Breuer, William ^a   Ermers, Marieke J J ^a,b   Pootrakul, Pensri ^c   Abramov, Ayala ^d   Hershko, Chaim ^d   Ioav Cabantchik, Z ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAHIDOL UNIVERSITY   (Thailand)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FLUORESCEIN; IRON; IRON CHELATING AGENT; TRANSFERRIN;

BETA THALASSEMIA; BLOOD TRANSFUSION; CONFERENCE PAPER; CONTROLLED STUDY; HEMOCHROMATOSIS; HEMOSIDEROSIS; HUMAN; IRON BINDING CAPACITY; IRON CHELATION; IRON OVERLOAD; MAJOR CLINICAL STUDY; PATIENT MONITORING;

BLOOD TRANSFUSION; CHELATING AGENTS; DEFEROXAMINE; DRUG MONITORING; HEMOSIDEROSIS; HUMANS; IRON;

EID: 0033677750     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00093-X     Document Type: Conference Paper

References (2)

1. Non-specific serum iron in thalassaemia: An abnormal serum iron fraction of potential toxicity
2. Quantification of non-transferrin bound iron in the presence of unsaturated transferrin